\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ soft\\ fontanelle\ \(0\)\
\-\ \\â\\€\\¢\\ normal\\ cranial\\ sutures\ \(0\)\
\-\ chemotherapy\\ planned\ \(0\)\
\-\ complex\\,\\ \\ large\\ mass\\ right\\ frontal\\ lobe\\ with\\ associated\\ hemorrhage\\ and\\ both\\ fluid\\ and\\ solid\\ components\\.\ \(0\)\
\-\ mass\\ enhances\\ minimally\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ \\â\\€\\¢\\ gliosarcoma\ \(0\)\
\-\ \\â\\€\\¢\\ pnet\\ \\(cerebral\\ neuroblastoma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ atypical\\ teratoid\\/rhabdoid\\ tumor\ \(1\)\
\-\ \\â\\€\\¢\\ teratoma\ \(2\)\
\-\ newborn\\ female\\ who\\ was\\ transferred\\ from\\ a\\ local\\ hospital\\ because\\ a\\ prenatal\\ ultrasound\\ showed\\ hydrocephalus\\ and\\ a\\ mass\\.\ \(0\)\
\-\ congenital\\ brain\\ tumors\\ are\\ rare\\ with\\ gbm\\ accounting\\ for\\ a\\ minority\\ of\\ them\\.\\ \\ the\\ most\\ common\\ congenital\\ brain\\ tumors\\ are\\ teratoma\\,\\ pnet\\ \\(incl\\.\\ medulloblastoma\\)\\,\\ astrocytoma\\ \\(incl\\.\\ gbm\\)\\,\\ and\\ choroid\\ plexus\\ papilloma\\.\\ pmid\\:\\ 2167004\ \(0\)\
\-\ glioblastomas\\ are\\ most\\ commonly\\ diagnosed\\ in\\ middle\\ aged\\ to\\ older\\ adults\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ incl\\:\\ 0\\.35263836575906554\ \(0\)\
\-\ pnet\\:\\ 0\\.23683591485967476\ \(0\)\
\-\ gbm\\:\\ 0\\.23315162287055502\ \(0\)\
\-\ teratoma\\:\\ 0\\.19068387742512302\ \(0\)\
\-\ glioblastomas\\:\\ 0\\.17631918287953277\ \(0\)\
\-\ 2167004\\:\\ 0\\.16848239224112768\ \(0\)\
\-\ tumors\\:\\ 0\\.16217139446748827\ \(0\)\
\-\ congenital\\:\\ 0\\.15843620608158743\ \(0\)\
\-\ minority\\:\\ 0\\.15508531015681679\ \(0\)\
\-\ gliosarcoma\\:\\ 0\\.1472485195184117\ \(0\)\
\-\ brain\\:\\ 0\\.1374633521269092\ \(0\)\
\-\ fontanelle\\:\\ 0\\.13495618976304224\ \(0\)\
\-\ sutures\\:\\ 0\\.13181503951414827\ \(0\)\
\-\ accounting\\:\\ 0\\.13087202791052774\ \(0\)\
\-\ mass\\:\\ 0\\.12634156241377287\ \(0\)\
\-\ are\\:\\ 0\\.12550844877624498\ \(0\)\
\-\ pmid\\:\\ 0\\.12099883935217014\ \(0\)\
\-\ aged\\:\\ 0\\.1204543553497899\ \(0\)\
\-\ them\\:\\ 0\\.11992479061012298\ \(0\)\
\-\ multiforme\\:\\ 0\\.1148940639038841\ \(0\)\
\-\ most\\:\\ 0\\.1147584121060346\ \(0\)\
\-\ medulloblastoma\\:\\ 0\\.11449553630264381\ \(0\)\
\-\ planned\\:\\ 0\\.11297884446165712\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.10994740824748964\ \(0\)\
\-\ newborn\\:\\ 0\\.10873902079687241\ \(0\)\
\-\ prenatal\\:\\ 0\\.10873902079687241\ \(0\)\
\-\ transferred\\:\\ 0\\.10787986140236593\ \(0\)\
\-\ minimally\\:\\ 0\\.10454361890269993\ \(0\)\
\-\ choroid\\:\\ 0\\.10339962208538128\ \(0\)\
\-\ adults\\:\\ 0\\.10296033263307063\ \(0\)\
\-\ older\\:\\ 0\\.10231956995646013\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.10129669086776512\ \(0\)\
\-\ papilloma\\:\\ 0\\.10109845421833291\ \(0\)\
\-\ components\\:\\ 0\\.10013666854438204\ \(0\)\
\-\ plexus\\:\\ 0\\.09940027837835551\ \(0\)\
\-\ enhances\\:\\ 0\\.09718408470712138\ \(0\)\
\-\ local\\:\\ 0\\.09490758551462208\ \(0\)\
\-\ and\\:\\ 0\\.09113005805219111\ \(0\)\
\-\ atypical\\:\\ 0\\.09045204639765773\ \(0\)\
\-\ cranial\\:\\ 0\\.09011394033185965\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.09000254000107036\ \(0\)\
\-\ administration\\:\\ 0\\.08780023630807357\ \(0\)\
\-\ complex\\:\\ 0\\.0849486854903662\ \(0\)\
\-\ solid\\:\\ 0\\.08452573855058336\ \(0\)\
\-\ rare\\:\\ 0\\.0832313367260568\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.0832313367260568\ \(0\)\
\-\ commonly\\:\\ 0\\.08158222115224664\ \(0\)\
\-\ hospital\\:\\ 0\\.08143905083919123\ \(0\)\
\-\ diagnosed\\:\\ 0\\.0798645814956169\ \(0\)\
\-\ middle\\:\\ 0\\.07884034696641602\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0782872054481529\ \(0\)\
\-\ because\\:\\ 0\\.07705496431334684\ \(0\)\
\-\ cerebral\\:\\ 0\\.07638456518234482\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.07381741534150299\ \(0\)\
\-\ showed\\:\\ 0\\.07343655762162632\ \(0\)\
\-\ frontal\\:\\ 0\\.07096203557329894\ \(0\)\
\-\ ultrasound\\:\\ 0\\.06800634127219252\ \(0\)\
\-\ following\\:\\ 0\\.06614155738879055\ \(0\)\
\-\ lobe\\:\\ 0\\.0637148127676502\ \(0\)\
\-\ fluid\\:\\ 0\\.06365788222903594\ \(0\)\
\-\ common\\:\\ 0\\.06252630421378208\ \(0\)\
\-\ who\\:\\ 0\\.062366127297991965\ \(0\)\
\-\ both\\:\\ 0\\.061482709108106874\ \(0\)\
\-\ soft\\:\\ 0\\.058696562001463476\ \(0\)\
\-\ associated\\:\\ 0\\.05811180770461369\ \(0\)\
\-\ tumor\\:\\ 0\\.05766892309895003\ \(0\)\
\-\ large\\:\\ 0\\.05524242449648758\ \(0\)\
\-\ contrast\\:\\ 0\\.05356987415959815\ \(0\)\
\-\ female\\:\\ 0\\.053202348923801025\ \(0\)\
\-\ normal\\:\\ 0\\.04501572242018602\ \(0\)\
\-\ from\\:\\ 0\\.043787974742332016\ \(0\)\
\-\ with\\:\\ 0\\.04317798672408578\ \(0\)\
\-\ was\\:\\ 0\\.0384244001619788\ \(0\)\
\-\ right\\:\\ 0\\.036553562692018496\ \(0\)\
\-\ for\\:\\ 0\\.033416958251724825\ \(0\)\
\-\ to\\:\\ 0\\.027563132498175442\ \(0\)\
\-\ in\\:\\ 0\\.02742746681710463\ \(0\)\
\-\ the\\:\\ 0\\.021999547552409005\ \(0\)\
\-\ of\\:\\ 0\\.02157610164645044\ \(0\)\
